Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felipe Villacampa

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Archivos Espanoles De Urologia|May 17, 2013
Castleman's disease presented as a retroperitoneal massFernando Cabrera, Felipe Villacampa, Gemma Duque, et al.
Translational Andrology and Urology|May 9, 2024
Chemoablation with UGN-102 in intermediate-risk non-muscle invasive bladder cancer, are we there yet?Daniel A González-Padilla, José Daniel Subiela, Felipe Villacampa-Aubá
The Journal of Urology|November 25, 2025
Immune checkpoint inhibitors for high-risk non-muscle invasive bladder cancer: Lessons learnt from the CREST and POTOMAC trialsDaniel A González-Padilla, José Daniel Subiela, Felipe Villacampa-Aubá
Archivos Espanoles De Urologia|September 14, 2012
Early treatment of penile fractures: our experienceBorja García Gómez, Javier Romero, Felipe Villacampa, et al.
Clinical Kidney Journal|December 12, 2017
Recommendations for imaging-based diagnosis and management of renal angiomyolipoma associated with tuberous sclerosis complexMaría José Buj Pradilla, Teresa Martí Ballesté, Roser Torra, et al.
Archivos Espanoles De Urologia|January 17, 2018
[Training program in endourological surgery. Future perspectives.]Federico Soria, Felipe Villacampa, Alvaro Serrano, et al.
International Urogynecology Journal|November 1, 2012
Predicting self-perceived antimuscarinic therapy effectiveness on overactive bladder symptoms using the Overactive Bladder 8-Question Awareness ToolFelipe Villacampa, Miguel A Ruiz, Carlos Errando, et al.
Clinical Drug Investigation|June 30, 2012
Quality of life in patients with overactive bladder: validation and psychometric properties of the Spanish Overactive Bladder Questionnaire-short FormSalvador Arlandis, Miguel A Ruiz, Carlos Errando, et al.
Archivos Espanoles De Urologia|April 11, 2018
[The role of chemotherapy in the treatment of hormone sensitive metastatic prostate cancer.]José Luis Pérez-Gracia, Fernando Diez Caballero, Alfonso Gúrpide, et al.
Archivos Espanoles De Urologia|November 22, 2005
[Adenocarcinoma of the female urethra: report of two cases and bibliography review]Javier Amalio Feltes Ochoa, Ovidio Blanco Carballo, Tejido Sánchez Angel, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Archivos Espanoles De Urologia|May 17, 2013
Castleman's disease presented as a retroperitoneal massFernando Cabrera, Felipe Villacampa, Gemma Duque, et al.
Translational Andrology and Urology|May 9, 2024
Chemoablation with UGN-102 in intermediate-risk non-muscle invasive bladder cancer, are we there yet?Daniel A González-Padilla, José Daniel Subiela, Felipe Villacampa-Aubá
The Journal of Urology|November 25, 2025
Immune checkpoint inhibitors for high-risk non-muscle invasive bladder cancer: Lessons learnt from the CREST and POTOMAC trialsDaniel A González-Padilla, José Daniel Subiela, Felipe Villacampa-Aubá
Archivos Espanoles De Urologia|September 14, 2012
Early treatment of penile fractures: our experienceBorja García Gómez, Javier Romero, Felipe Villacampa, et al.
Clinical Kidney Journal|December 12, 2017
Recommendations for imaging-based diagnosis and management of renal angiomyolipoma associated with tuberous sclerosis complexMaría José Buj Pradilla, Teresa Martí Ballesté, Roser Torra, et al.
Archivos Espanoles De Urologia|January 17, 2018
[Training program in endourological surgery. Future perspectives.]Federico Soria, Felipe Villacampa, Alvaro Serrano, et al.
International Urogynecology Journal|November 1, 2012
Predicting self-perceived antimuscarinic therapy effectiveness on overactive bladder symptoms using the Overactive Bladder 8-Question Awareness ToolFelipe Villacampa, Miguel A Ruiz, Carlos Errando, et al.
Clinical Drug Investigation|June 30, 2012
Quality of life in patients with overactive bladder: validation and psychometric properties of the Spanish Overactive Bladder Questionnaire-short FormSalvador Arlandis, Miguel A Ruiz, Carlos Errando, et al.
Archivos Espanoles De Urologia|April 11, 2018
[The role of chemotherapy in the treatment of hormone sensitive metastatic prostate cancer.]José Luis Pérez-Gracia, Fernando Diez Caballero, Alfonso Gúrpide, et al.
Archivos Espanoles De Urologia|November 22, 2005
[Adenocarcinoma of the female urethra: report of two cases and bibliography review]Javier Amalio Feltes Ochoa, Ovidio Blanco Carballo, Tejido Sánchez Angel, et al.
Pageof 5